Angiogenic factors: Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma

Anticancer Research

Volumn 21, Issue 2 B, 2001, Pages 1423-1430

  Edgren, M ^a   Lennernas B ^a   Larsson, A ^a   Kalkner K M ^a  

^a Oncology Clinic   (Sweden)

Author keywords

Angiogenesis; B FGF; Metastasis; Prognosis; Renal cell carcinoma; Survival; VEGF

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; TUMOR MARKER; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; KIDNEY NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035019968     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Clinical applications of research on angiogenesis
2. What is the evidence that tumors are angiogenesis dependent?
3. Altered angiogenesis uderlying age-dependent changes in tumor growth
4. Clinical importance of the determination of tumour angiogenesis in breast carcinoma: Mqch more than prognostic tool
5. Elevated levels of the angiogenetic cytokinas basic fibroblast growth factor and vascular endothelium growth factor in sera of cancer patients
6. Increased serum levels of basic fibroblast factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients
7. Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cep carcinoma treated with Interferon Alfa-2b
8. Angiogenesis: Mechanistics insights, neovascular diseases, and therapeutic prospects
9. Serum concentration of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas
10. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
11. Vascular endothelial growth factor expression in renal cell carcinoma
12. Expression of angiogenic factors in renal cell carcinomas
13. Renal cell carcinoma: Relevance of angiogenetic factors
14. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms tumor patients
15. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinomas?
16. Von Hippel-Lindau disease: Recent genetic progress and patient management
17. The role of platelet derived endothelial cell growth factor (PD-ECGF) in the angiogenesis of human colon cancer
18. Symptomatology of anemia. ESMO Evolving, issues in oncology. What is the "optimal" hemoglobin level?
19. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma
20. Thalidomide is an inhibitor of angiogenesis
21. Vascular endothelial growth factor (VEGF) serum levels during cancer immunotherapy with IL-2: Preliminary consideration
22. Potention of the angiogenetic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers
23. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation